NASDAQ · Biotechnology

XERS (XERS) Stock

$8.19 +0.74% NASDAQ: XERS Healthcare

Valuation

MetricValue
Price$8.19
Market Cap$1.41B
P/E Ratio89.43
P/B Ratio76.34
P/S Ratio3.43
EPS (TTM)$0.07
52-Week High$10.08
52-Week Low$4.40
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE80.95%
ROA6.34%
ROCE178.57%
Gross Margin81.59%
Operating Margin11.40%
Net Margin3.81%
Debt/Equity2.87
Current Ratio2.18

Annual Financials (USD)

Metric20212022202320242025
Revenue$50.0M$110.0M$164.0M$203.0M$292.0M
Operating Profit$-115.0M$-82.0M$-44.0M$-34.0M$25.0M
Net Profit$-123.0M$-95.0M$-62.0M$-55.0M$1.0M
EPS$-1.55$-0.70$-0.45$-0.37$0.00
Op Margin-232.2%-74.3%-26.9%-16.6%8.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$304.0M$345.0M$323.0M$323.0M$384.0M
Total Liabilities$209.0M$299.0M$329.0M$353.0M$370.0M
Cash$67.0M$122.0M$67.0M$72.0M$111.0M
Borrowings$88.0M$198.0M$229.0M$271.0M$38.0M

Latest News

Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last? Zacks · Jul 8, 2026 Xeris Biopharma Holdings Insider Sold Shares Worth $383,176, According to a Recent SEC Filing MT Newswires · Jul 7, 2026 CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Business Wire · Jul 3, 2026 Is Xeris Biopharma Holdings, Inc. (XERS) Stock Positioned for Long-Term Growth With Extended Keveyis Exclusivity? Insider Monkey · Jun 30, 2026 Xeris Biopharma Appoints CEO John Shannon Board Chair MT Newswires · Jun 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-103.0M$-103.0M$-47.0M$-37.0M$29.0M
Investing Cash Flow$34.0M$34.0M$-8.0M$4.0M$-1.0M
Financing Cash Flow$-1.0M$-5.0M$-2.0M$-2.0M$-11.0M
Net Cash Flow$59.0M$59.0M$-55.0M$4.0M$39.0M
Free Cash Flow$-103.0M$-103.0M$-49.0M$-38.0M$28.0M

Valuation & Return Ratios

MetricValue
PEG Ratio88.53
EV / EBITDA25.53
FCF Yield4.37%
Quick Ratio1.50
Interest Coverage0.86
Return 1Y64.26%
Return 3Y233.73%
Return 5Y134.56%

Ownership

Insiders Held3.38%
Institutions Held62.61%
Institutions Float Held64.80%
Institutional HolderSharesReport Date
Blackrock Inc.12,945,7852026-03-31
Shaw D.E. & Co., Inc.7,788,8112026-03-31
Vanguard Capital Management LLC6,980,8822026-03-31
State Street Corporation4,658,1742026-03-31
Geode Capital Management, LLC4,290,6292026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABCL $6.93 +6.13% -5.91 $2.12B 0.00%
BCRXBioCryst Pharmaceuticals, Inc. $9.75 +4.39% -5.40 $2.48B 0.00%
BHVN $14.07 +3.19% -6.11 $2.12B 0.00%
CLDX $35.80 +0.63% -7.84 $2.38B 0.00%
HRMY $38.24 -1.39% 11.23 $2.21B 0.00%

About XERS

XERS is led by CEO John Shannon, publicly traded since 2018.

XERS stock trades at $8.19 with a market capitalization of $1.41B. The stock is valued at a price-to-earnings (P/E) ratio of 89.43, price-to-book of 76.34, price-to-sales of 3.43. Over the past 52 weeks the stock has ranged between $4.40 and $10.08, and currently trades 18.8% below its 52-week high.

On profitability, XERS generates a return on equity (ROE) of 80.95% — well above the market average, a sign of a high-quality business, return on capital employed of 178.57%, an operating margin of 11.40%, a net profit margin of 3.81%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides